FN1: A novel fusion partner of ALK in an inflammatory myofibroblastic tumor

Pediatric Blood and Cancer

Volumn 62, Issue 5, 2015, Pages 909-911

  Ouchi, Kazutaka ^a   Miyachi, Mitsuru ^a   Tsuma, Yusuke ^a   Tsuchiya, Kunihiko ^a   Iehara, Tomoko ^a   Konishi, Eiichi ^b   Yanagisawa, Akio ^b   Hosoi, Hajime ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

ALK gene fusion; FN1; Inflammatory myofibroblastic tumor

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANAPLASTIC LYMPHOMA KINASE; ANAPLASTIC LYMPHOMA KINASE FIBRONECTIN 1 FUSION PROTEIN; COMPLEMENTARY DNA; FIBRONECTIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYBRID PROTEIN; MELOXICAM; UNCLASSIFIED DRUG; FN1 PROTEIN, HUMAN; MESSENGER RNA; ONCOPROTEIN; PROTEIN TYROSINE KINASE;

ARTICLE; BASOPHIL; BLADDER BIOPSY; BLADDER TUMOR; CANCER ADJUVANT THERAPY; CANCER CELL LINE; CASE REPORT; CELL PROLIFERATION; CHILD; CONTROLLED STUDY; CYSTECTOMY; DNA SEQUENCE; EOSINOPHIL; EXON; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; MALE; PLASMA CELL GRANULOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SPINDLE CELL; TUMOR BIOPSY; ENZYME IMMUNOASSAY; GENETICS; INFLAMMATION; METABOLISM; MUSCLE TUMOR; MYOFIBROBLAST; PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION;

CHILD; FIBRONECTINS; GRANULOMA, PLASMA CELL; HUMANS; IMMUNOENZYME TECHNIQUES; INFLAMMATION; MALE; MYOFIBROBLASTS; NEOPLASMS, MUSCLE TISSUE; ONCOGENE PROTEINS, FUSION; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR PROTEIN-TYROSINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84925459543     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.25424     Document Type: Article

References (9)

1. Pettinato G, Manivel JC, De Rosa N, Dehner LP. Inflammatory myofibroblastic tumor (plasma cell granuloma). Clinicopathologic study of 20 cases with immunohistochemical and ultrastructural observations. Am J Clin Pathol 1990; 94:538-546.
2. Netto JM, Perez LM, Kelly DR, Joseph DB. Pediatric inflammatory bladder tumors: Myofibroblastic and eosinophilic subtypes. J Urol 1999; 162:1424-1429.
3. Coffin CM, Patel A, Perkins S, Elenitoba-Johnson KS, Perlman E, Griffin CA. ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor. Mod Pathol 2001; 14:569-576.
4. Takeuchi K, Soda M, Togashi Y, Sugawara E, Hatano S, Asaka R, Okumura S, Nakagawa K, Mano H, Ishikawa Y. Pulmonary inflammatory myofibroblastic tumor expressing a novel fusion, PPFIBP1-ALK: Reappraisal of anti-ALK immunohistochemistry as a tool for novel ALK fusion identification. Clin Cancer Rese 2011; 17:3341-3348.
5. Cools J, Wlodarska I, Somers R, Mentens N, Pedeutour F, Maes B, De Wolf-Peeters C, Pauwels P, Hagemeijer A, Marynen P. Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor. Genes Chromosomes Cancer 2002; 34:354-362.
6. Hallberg B, Palmer RH. Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology. Nature Rev Cancer 2013; 13:685-700.
7. Mao Y, Schwarzbauer JE. Fibronectin fibrillogenesis, a cell-mediated matrix assembly process. Matrix Biol 2005; 24:389-399.
8. Ren H, Tan ZP, Zhu X, Crosby K, Haack H, Ren JM, Beausoleil S, Moritz A, Innocenti G, Rush J, Zhang Y, Zhou XM, Gu TL, Yang YF, Comb MJ. Identification of anaplastic lymphoma kinase as a potential therapeutic target in ovarian cancer. Cancer Res 2012; 72:3312-3323.
9. Butrynski JE, D'Adamo DR, Hornick JL, Dal Cin P, Antonescu CR, Jhanwar SC, Ladanyi M, Capelletti M, Rodig SJ, Ramaiya N, Kwak EL, Clark JW, Wilner KD, Christensen JG, Janne PA, Maki RG, Demetri GD, Shapiro GI. Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. N Engl J Med 2010; 363:1727-1733.